MAIA Biotechnology

MAIANYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$86.337 M

$1.42 +0.00%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

60,671,491

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#314Verrica PharmaceuticalsVRCA$87.3M
#315Gossamer BioGOSS$87.0M
#316MAIA BiotechnologyMAIA$86.3M
#317RallybioRLYB$85.6M
#318LifevantageLFVN$85.3M

Where these numbers come from

Share counts and financials for MAIA Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.